Equate — Ointment

Overview

Brand name

Equate

Generic name

Bacitracin Zinc Antibiotic Ointment

Dosage form

Ointment

Route

Topical

Marketing category

OTC MONOGRAPH DRUG · OTC MONO

Labeler

Walmart Inc.

Product type

Human Otc Drug

DEA schedule

Not scheduled

Active ingredients

4

NDC product codes

2

Packages

2

Data completeness

76% of corroborating sources present

Active ingredients

Source: NDC Directory

Active ingredients and strengths as listed in the NDC Directory.
Ingredient	Strength	RxCUI	Monograph
Bacitracin Zinc	500 [USP'U]/g	204602	View
Camphor (SYNTHETIC)	4.8 g/100g	1793147	—
Eucalyptus Oil	1.2 g/100g	1547992	—
Menthol	2.6 g/100g	1947261	View

Forms, strengths and routes

Source: NDC Directory

Dosage form

Ointment

Route of administration

Topical

Presentations

4

Pharmacologic classes are listed in the class section below.

Pharmacologic class

Source: NDC Directory

Established pharmacologic classes (EPC), mechanisms of action (MoA), chemical structures (CS) and physiologic effects (PE).
Class	Type	Browse
Decreased Cell Wall Synthesis & Repair [PE]	PE	All 41 members

Regulatory status

Source: Drugs@FDA NDC Directory

Application number

000004

Application type

M

Approval date

July 16, 1969

Sponsor

PHARMICS

Products on application

1

Submissions recorded

3

Products approved under application 000004.
Product	Trade name	Form	Strength	Ingredient	Status	TE	Flags
000004-004	PAREDRINE	SOLUTION/DROPS		HYDROXYAMPHETAMINE HYDROBROMIDE	Discontinued	—

Approval history

Source: Drugs@FDA

Most recent submissions on application 000004.
Type	No.	Action	Status	Date	Review
Supplement	11	Labeling	Approved	May 26, 1987	—
Supplement	10	Labeling	Approved	May 8, 1980	—
Original application	1		Approved	July 16, 1969	Unknown

Prescribing information

Source: openFDA Drug Labeling

Reproduced verbatim from the Structured Product Labeling submitted to the FDA (effective 20251008). This is the manufacturer's labelling text, not a summary and not advice.

HUMAN OTC DRUG · 20251008 HUMAN OTC DRUG · 20250201

Indications and Usage

openFDA Drug Labeling

Uses temporarily relieves cough due to minor throat and bronchial irritation associated with a cold temporarily relieves minor aches and pains of muscles and joints

Purpose

openFDA Drug Labeling

Purpose Cough suppressant & topical analgesic

Dosage and Administration

openFDA Drug Labeling

Directions See important warnings under "When using this product" • adults and children 2 years and over: > Rub a thick layer on the throat and chest for cough, or rub on sore aching muscles or joints > Clothing should be left loose about the throat and chest to help vapors reach the nose and mouth > Use up to 3 times daily or as directed by doctor Cover with a warm, dry cloth if desired • children under 2 years: do not use

Warnings

openFDA Drug Labeling

Warnings For external use only; avoid contact with eyes. Do not use by mouth in nostrils on wounds or damaged skin with tight bandages Ask a doctor before use if you have cough that occurs with too much phlegm (mucus) persistent or chronic cough such as occurs with smoking, asthma or emphysema When using this product, do not heat microwave add to hot water or any container where heating water. May cause splattering and result in burns. Stop use and ask a doctor if muscle aches and pains worsen or persist for more than 7 days or clear up and occur again within a few days. cough persists for more than 1 week, tends to recur, or is accompanied by fever, rash, or persistent headache. A persistent cough may be a sign of a serious condition. If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Do Not Use

openFDA Drug Labeling

DO NOT USE if you are allergic to any of the ingredients in the eyes over large areas of the body

Ask a Doctor

openFDA Drug Labeling

Ask a doctor before use if you have cough that occurs with too much phlegm (mucus) persistent or chronic cough such as occurs with smoking, asthma or emphysema

Stop Use

openFDA Drug Labeling

Stop use and ask a doctor if muscle aches and pains worsen or persist for more than 7 days or clear up and occur again within a few days. cough persists for more than 1 week, tends to recur, or is accompanied by fever, rash, or persistent headache. A persistent cough may be a sign of a serious condition.

Active Ingredient

openFDA Drug Labeling

Active ingredients Camphor (synthetic) 4.8% .....................................................Cough suppressant & topical analgesic Eucalyptus Oil 1.2% .............................................................. Cough suppressant Menthol 2.6% .........................................................................Cough suppressant & topical analgesic

Adverse event reports

Source: openFDA FAERS

54,494

FAERS reports mentioning this drug

as of 2026-09-25T03:42:24+00:00

A report count is not a risk measure. FAERS accepts voluntary and mandatory reports without establishing causation, and reporting is influenced by how widely a drug is used, how long it has been marketed, and media attention. FDA states that reports “do not prove that the drug caused the event”. Compare rates, not totals.

Attributed to this product's most-reported active ingredient: MENTHOL. Combination products with more than six active ingredients are not attributed, because a report count summed across a long ingredient list measures the list, not the medicine.

Packaging and NDCs

Source: NDC Directory

Every National Drug Code package associated with this medication. The NDC is the identifier used for dispensing, billing and pharmacovigilance in the United States.
Package NDC	Product NDC	Labeler	Description	Marketing start
79903-194-17	79903-194	Walmart Inc	1 JAR in 1 CARTON (79903-194-17) / 50 g in 1 JAR	August 1, 2023
79903-372-01	79903-372	Walmart Inc.	1 TUBE in 1 CARTON (79903-372-01) / 28 g in 1 TUBE	January 27, 2025
79903-194	79903-194	Walmart Inc	—	August 1, 2023
79903-372	79903-372	Walmart Inc.	—	January 27, 2025

Sources for this page

Every dataset that contributed a fact to this page.
Dataset	Agency	Used for
NDC Directory	FDA	Identity, ingredients, strengths, forms, routes, labelers, packages
Drugs@FDA	FDA	Application, sponsor, submissions, review documents, marketing status
Drug Labeling	FDA / NLM	Prescribing information reproduced above
FAERS	FDA	Adverse event report counts

Generated September 25, 2026 · 10 sections on this page.